saxagliptin

AstraZeneca diabetes drug combination faces delay after FDA rebuff
Yahoo/Reuters
Fri, 10/16/15 - 06:58 am
AstraZeneca
diabetes
FDA
saxagliptin
Dapagliflozin
Is 'No Worse Than Placebo' Good Enough For New Diabetes Drugs?
Forbes
Tue, 09/3/13 - 11:07 am
diabetes
saxagliptin
alogliptin
AstraZeneca
Bristol-Myers Squibb
Takeda
Bristol-Myers, Novo Nordisk diabetes drugs face FDA review, while Amylin preps for application
Yahoo/AP
Thu, 03/26/09 - 02:47 pm
Bristol-Myers Squibb
Novo Nordisk
FDA
Amylin
Alkermes
saxagliptin
Byetta
Diabetes Drugs to Face Tougher Risk Scrutiny
WSJ Online
Thu, 12/18/08 - 07:15 am
diabetes
GSK
Avandia
Eli Lilly
Amylin
Byetta
Bristol-Myers Squibb
AstraZeneca
saxagliptin